ArticlePilot and feasibility studies2025
Feasibility of a prospective multicenter observational study-is diabetes a risk factor in ERAS joint arthroplasty?
Article in Pilot and feasibility studies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05613439 (The Fast-track Centre for Hip and Knee Replacement Prospective Database on Preoperative Patientcharacteristics and Postoperative Complications), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Fast-track Centre for Hip and Knee Replacement Prospective Database on Preoperative Patientcharacteristics and Postoperative Complications
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundDiabetes mellitus is a surgical risk factor, yet perioperative diabetes management remains debated, with inconsistent guidelines and limited consideration on the implementation of "enhanced recovery after surgery" (ERAS) programs. A detailed prospective observational multicenter study was launched to investigate perioperative risk factors and outcomes in diabetic patients undergoing modern optimized hip and knee arthroplasty within an established ERAS program.
methodsThis study reports on the feasibility of launching prospective detailed observational studies as part of daily clinical practice within a multicenter collaboration, focusing on data completeness and successful recruitment.The feasibility analysis was conducted from October 1, 2022, to January 31, 2024, across eight public arthroplasty centers in Denmark, in diabetic patients undergoing elective primary total hip (THA), total knee (TKA), or unicompartmental knee (UKA) arthroplasty. Prospective data collection included antihyperglycemic medication, preoperative HbA1c, data on perioperative diabetes management, length of stay (LOS), and readmission after surgery.
resultsThe cohort comprised 1007 DM patients (37.6% (n = 379) THA, 44.5% (n = 448) TKA, 17.9% (n = 180) UKA) with a mean age of 70.7 years (SD 8.8), and the median age was 71 (IQR 65-77); 48% were female and 19% were insulin-treated. Data on the type of preoperative antihyperglycemic medications was available in 100% of patients. LOS was registered in 100% of patients, and 90-day follow-up was completed in 99% of patients. Preoperative HbA1c assessment increased from 68% in February 2023 to 96% in January 2024. From March 1st, 2023, data on perioperative diabetes management was available for 98% of all patients, with a total completion variation between 94 and 96% across the included parameters.
conclusionThe study demonstrates the feasibility of a prospective multicenter setup for detailed data collection on diabetic patients undergoing ERAS hip or knee arthroplasty. The high compliance rates of key metrics (≥ 94%) support that data completeness and quality are sufficient to proceed with the main study to assess the impact of diabetes and its management on outcomes within an ERAS program in 2000 patients, since enrollment exceeded expectations.
trial registrationClinicalTrials.gov. NCT05613439. Registered on 9 January 2022, https://clinicaltrials.gov/study/NCT05613439?id=NCT05613439&rank=1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.